SIRT for Potentially Resectable HCC

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 10, 2023

Primary Completion Date

August 9, 2026

Study Completion Date

February 9, 2027

Conditions
Hepatocellular Carcinoma
Interventions
PROCEDURE

SIRT

The patients will receive 1-2 sessions of SIRT. If the patients have invasive tumors, extensive liver involvement or vascular invasion, systematic treatment will be added.

Trial Locations (1)

510260

RECRUITING

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

All Listed Sponsors
lead

Second Affiliated Hospital of Guangzhou Medical University

OTHER